EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE

The article presents the results of clinical studies of the effectiveness of artificial pneumothorax in the treatment of 124 patients with cavernous pulmonary tuberculosis patients and extensively drug resistance. Clinical trials of the use of artificial pneumothorax in young patients with cavernous...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	I. A. Morozov, V. Y. Mishin, O. A. Osadchaya, A. V. Mishina, A. L. Sobkin, D. D. Petrov
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2016
Materias:	pulmonary tuberculosis drug-resistant mycobacterium tuberculosis artificial pneumothorax Science Q
Acceso en línea:	https://doaj.org/article/9b8f265f8e84468d9613414342df0631
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9b8f265f8e84468d9613414342df0631
record_format	dspace
spelling	oai:doaj.org-article:9b8f265f8e84468d9613414342df06312021-11-23T06:14:36ZEFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE2541-94202587-959610.12737/23748https://doaj.org/article/9b8f265f8e84468d9613414342df06312016-11-01T00:00:00Zhttps://www.actabiomedica.ru/jour/article/view/325https://doaj.org/toc/2541-9420https://doaj.org/toc/2587-9596The article presents the results of clinical studies of the effectiveness of artificial pneumothorax in the treatment of 124 patients with cavernous pulmonary tuberculosis patients and extensively drug resistance. Clinical trials of the use of artificial pneumothorax in young patients with cavernous pulmonary tuberculosis MDR and XDR MBT have proved its high efficiency and that it can be recommended for widespread clinical use. The indications for the use of artificial pneumothorax is a cavernous pulmonary tuberculosis with the release of MDR and XDR MBT with unformed or formed thin-walled cavity not larger than 4 cm in diameter. Pleuropulmonary adhesions revealed at primary application of artificial pneumothorax are the direct indications fpr surgical burn of adhesions. With the diameter of cavities up to 2 cm the artificial pneumothorax treatment is applied for 6 months and with cavities of 2-4 cm in diameter - for 12 months. Contraindications to the use of artificial pneumothorax are cavities in the lungs more than 4 cm in diameter, massive pleural commissures, with the impossibility of their surgical burnout; specific lesion bronchial tubes and severe comorbidities (mental illness, organic lesions of the central nervous system, chronic obstructive lung disease, chronic cardiovascular diseases in the stage of decompensation, congenital malformations of the heart and lungs, chest wall deformity). Treatment of patients with artificial pneumothorax cavernous pulmonary tuberculosis MDR and XDR pathogen can be recommended for use in stationary phase in TB facilities with thoracic surgery, where the implementation of operational burnout pleural commissures is possible.I. A. MorozovV. Y. MishinO. A. OsadchayaA. V. MishinaA. L. SobkinD. D. PetrovScientific Сentre for Family Health and Human Reproduction Problemsarticlepulmonary tuberculosisdrug-resistant mycobacterium tuberculosisartificial pneumothoraxScienceQRUActa Biomedica Scientifica, Vol 1, Iss 6, Pp 82-87 (2016)
institution	DOAJ
collection	DOAJ
language	RU
topic	pulmonary tuberculosis drug-resistant mycobacterium tuberculosis artificial pneumothorax Science Q
spellingShingle	pulmonary tuberculosis drug-resistant mycobacterium tuberculosis artificial pneumothorax Science Q I. A. Morozov V. Y. Mishin O. A. Osadchaya A. V. Mishina A. L. Sobkin D. D. Petrov EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
description	The article presents the results of clinical studies of the effectiveness of artificial pneumothorax in the treatment of 124 patients with cavernous pulmonary tuberculosis patients and extensively drug resistance. Clinical trials of the use of artificial pneumothorax in young patients with cavernous pulmonary tuberculosis MDR and XDR MBT have proved its high efficiency and that it can be recommended for widespread clinical use. The indications for the use of artificial pneumothorax is a cavernous pulmonary tuberculosis with the release of MDR and XDR MBT with unformed or formed thin-walled cavity not larger than 4 cm in diameter. Pleuropulmonary adhesions revealed at primary application of artificial pneumothorax are the direct indications fpr surgical burn of adhesions. With the diameter of cavities up to 2 cm the artificial pneumothorax treatment is applied for 6 months and with cavities of 2-4 cm in diameter - for 12 months. Contraindications to the use of artificial pneumothorax are cavities in the lungs more than 4 cm in diameter, massive pleural commissures, with the impossibility of their surgical burnout; specific lesion bronchial tubes and severe comorbidities (mental illness, organic lesions of the central nervous system, chronic obstructive lung disease, chronic cardiovascular diseases in the stage of decompensation, congenital malformations of the heart and lungs, chest wall deformity). Treatment of patients with artificial pneumothorax cavernous pulmonary tuberculosis MDR and XDR pathogen can be recommended for use in stationary phase in TB facilities with thoracic surgery, where the implementation of operational burnout pleural commissures is possible.
format	article
author	I. A. Morozov V. Y. Mishin O. A. Osadchaya A. V. Mishina A. L. Sobkin D. D. Petrov
author_facet	I. A. Morozov V. Y. Mishin O. A. Osadchaya A. V. Mishina A. L. Sobkin D. D. Petrov
author_sort	I. A. Morozov
title	EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
title_short	EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
title_full	EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
title_fullStr	EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
title_full_unstemmed	EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE
title_sort	effectiveness of artificial pneumothorax in young patients with cavernous pulmonary tuberculosis multidrug and extensively drug bacterial resistance
publisher	Scientific Сentre for Family Health and Human Reproduction Problems
publishDate	2016
url	https://doaj.org/article/9b8f265f8e84468d9613414342df0631
work_keys_str_mv	AT iamorozov effectivenessofartificialpneumothoraxinyoungpatientswithcavernouspulmonarytuberculosismultidrugandextensivelydrugbacterialresistance AT vymishin effectivenessofartificialpneumothoraxinyoungpatientswithcavernouspulmonarytuberculosismultidrugandextensivelydrugbacterialresistance AT oaosadchaya effectivenessofartificialpneumothoraxinyoungpatientswithcavernouspulmonarytuberculosismultidrugandextensivelydrugbacterialresistance AT avmishina effectivenessofartificialpneumothoraxinyoungpatientswithcavernouspulmonarytuberculosismultidrugandextensivelydrugbacterialresistance AT alsobkin effectivenessofartificialpneumothoraxinyoungpatientswithcavernouspulmonarytuberculosismultidrugandextensivelydrugbacterialresistance AT ddpetrov effectivenessofartificialpneumothoraxinyoungpatientswithcavernouspulmonarytuberculosismultidrugandextensivelydrugbacterialresistance
_version_	1718417023052021760

EFFECTIVENESS OF ARTIFICIAL PNEUMOTHORAX IN YOUNG PATIENTS WITH CAVERNOUS PULMONARY TUBERCULOSIS MULTIDRUG AND EXTENSIVELY DRUG BACTERIAL RESISTANCE

Ejemplares similares